GB Patent

GB0301016D0 — Treatment of benign prostatic hyperplasia

Assigned to University College London · Expires 2003-02-19 · 23y expired

What this patent protects

Patent listed against belumosudil-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
GB0301016D0
Jurisdiction
GB
Classification
—
Expires
2003-02-19
Drug substance claim
No
Drug product claim
No
Assignee
University College London
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.